特発性肺線維症（IPF）は、原因不明の稀な慢性の衰弱性間質性肺疾患であり、進行性の肺損傷、炎症、そして侵襲性の線維化を特徴とします。病状が進行するにつれて、肺組織は肥厚し硬くなり、酸素を血流に運ぶ能力が著しく低下します。IPF患者は、息切れ、疲労、衰弱といった症状により日常生活に支障をきたし、極めて深刻な生活の質（QOL）の低下に直面します。IPF患者の予後は不良で、5年死亡率は60%から80%と推定されています。さらに、IPFは、慢性閉塞性肺高血圧症、閉塞性睡眠時無呼吸症、肺がん、虚血性心疾患、胃食道逆流症など、重篤な呼吸器系および非呼吸器系の合併症を伴うことが多くあります。これらの患者の大多数の死因は IPF自体です。
全世界でIPFに罹患している人は約300万人と推定され、アメリカだけでも約15万人が罹患しています。特発性肺線維症（IPF）治療薬の世界市場は、2025年までに45億〜55億米ドルの範囲で評価されると推定されています。患者診断と市場アクセスの拡大における一貫した1桁台前半の成長、そして既存薬に対するジェネリック医薬品の競争による価格下落の可能性が需要によって相殺されることから、市場は2030年まで3%〜6%の範囲の緩やかな年平均成長率（CAGR）で拡大すると予測されています。後期開発パイプラインから、疾患修飾性で忍容性の高い新たな治療薬が導入されれば、この成長を大幅に加速させる大きな商業機会が生まれます。
現在、IPFの治療薬として世界で承認されている抗線維化療法は2つだけです。どちらも病状の進行を遅らせる効果は示されていますが、臨床症状の悪化を回復または予防する効果はありません。
これらの既存の治療法はどちらも、IPFの複雑な病態における単一のメカニズムを標的としています。副作用プロファイルや機能的限界があるにもかかわらず、これら2つの治療法が商業的に大きな成功を収めていることは、より忍容性の高い疾患修飾治療薬が持つ莫大な商業的機会を裏付けています。
IPF治療薬市場は、満たされていない患者ニーズの高さと高い商業的リターンという魅力的な組み合わせを提示していますが、科学および規制上の大きな課題を克服する必要があります。
目次
Table of Contents
Chapter 1 Executive Summary
Chapter 2 Abbreviation and Acronyms
Chapter 3 Preface
3.1 Research Scope
3.2 Research Sources
3.2.1 Data Sources
3.2.2 Assumptions
3.3 Research Method
Chapter Four Market Landscape
4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users
Chapter 5 Market Trend Analysis
5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats
Chapter 6 Industry Chain Analysis
6.1 Upstream/Suppliers Analysis
6.2 Idiopathic Pulmonary Fibrosis Drugs Analysis
6.2.1 Technology Analysis
6.2.2 Cost Analysis
6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users
Chapter 7 Latest Market Dynamics
7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics
Chapter 8 Historical and Forecast Idiopathic Pulmonary Fibrosis Drugs Market in North America (2020-2030)
8.1 Idiopathic Pulmonary Fibrosis Drugs Market Size
8.2 Idiopathic Pulmonary Fibrosis Drugs Market by End Use
8.3 Competition by Players/Suppliers
8.4 Idiopathic Pulmonary Fibrosis Drugs Market Size by Type
8.5 Key Countries Analysis
8.5.1 United States
8.5.2 Canada
9.5.3 Mexico
Chapter 9 Historical and Forecast Idiopathic Pulmonary Fibrosis Drugs Market in South America (2020-2030)
9.1 Idiopathic Pulmonary Fibrosis Drugs Market Size
9.2 Idiopathic Pulmonary Fibrosis Drugs Market by End Use
9.3 Competition by Players/Suppliers
9.4 Idiopathic Pulmonary Fibrosis Drugs Market Size by Type
9.5 Key Countries Analysis
Chapter 10 Historical and Forecast Idiopathic Pulmonary Fibrosis Drugs Market in Asia & Pacific (2020-2030)
10.1 Idiopathic Pulmonary Fibrosis Drugs Market Size
10.2 Idiopathic Pulmonary Fibrosis Drugs Market by End Use
10.3 Competition by Players/Suppliers
10.4 Idiopathic Pulmonary Fibrosis Drugs Market Size by Type
10.5 Key Countries Analysis
10.5.1 China
10.5.2 India
10.5.3 Japan
10.5.4 South Korea
10.5.5 Southest Asia
10.5.6 Australia & New Zealand
Chapter 11 Historical and Forecast Idiopathic Pulmonary Fibrosis Drugs Market in Europe (2020-2030)
11.1 Idiopathic Pulmonary Fibrosis Drugs Market Size
11.2 Idiopathic Pulmonary Fibrosis Drugs Market by End Use
11.3 Competition by Players/Suppliers
11.4 Idiopathic Pulmonary Fibrosis Drugs Market Size by Type
11.5 Key Countries Analysis
11.5.1 Germany
11.5.2 France
11.5.3 United Kingdom
11.5.4 Italy
11.5.5 Spain
11.5.6 Belgium
11.5.7 Netherlands
11.5.8 Austria
11.5.9 Poland
11.5.10 Northern Europe
Chapter 12 Historical and Forecast Idiopathic Pulmonary Fibrosis Drugs Market in MEA (2020-2030)
12.1 Idiopathic Pulmonary Fibrosis Drugs Market Size
12.2 Idiopathic Pulmonary Fibrosis Drugs Market by End Use
12.3 Competition by Players/Suppliers
12.4 Idiopathic Pulmonary Fibrosis Drugs Market Size by Type
12.5 Key Countries Analysis
Chapter 13 Summary For Global Idiopathic Pulmonary Fibrosis Drugs Market (2020-2025)
13.1 Idiopathic Pulmonary Fibrosis Drugs Market Size
13.2 Idiopathic Pulmonary Fibrosis Drugs Market by End Use
13.3 Competition by Players/Suppliers
13.4 Idiopathic Pulmonary Fibrosis Drugs Market Size by Type
Chapter 14 Global Idiopathic Pulmonary Fibrosis Drugs Market Forecast (2025-2030)
14.1 Idiopathic Pulmonary Fibrosis Drugs Market Size Forecast
14.2 Idiopathic Pulmonary Fibrosis Drugs Application Forecast
14.3 Competition by Players/Suppliers
14.4 Idiopathic Pulmonary Fibrosis Drugs Type Forecast
Chapter 15 Analysis of Global Key Vendors
15.1 Boehringer Ingelheim
15.1.1 Company Profile
15.1.2 Main Business and Idiopathic Pulmonary Fibrosis Drugs Information
15.1.3 SWOT Analysis of Boehringer Ingelheim
15.1.4 Boehringer Ingelheim Idiopathic Pulmonary Fibrosis Drugs Revenue, Gross Margin and Market Share (2020-2025)
15.2 Roche
15.2.1 Company Profile
15.2.2 Main Business and Idiopathic Pulmonary Fibrosis Drugs Information
15.2.3 SWOT Analysis of Roche
15.2.4 Roche Idiopathic Pulmonary Fibrosis Drugs Revenue, Gross Margin and Market Share (2020-2025)
15.3 Sandoz
15.3.1 Company Profile
15.3.2 Main Business and Idiopathic Pulmonary Fibrosis Drugs Information
15.3.3 SWOT Analysis of Sandoz
15.3.4 Sandoz Idiopathic Pulmonary Fibrosis Drugs Revenue, Gross Margin and Market Share (2020-2025)
15.4 Teva Pharmaceutical
15.4.1 Company Profile
15.4.2 Main Business and Idiopathic Pulmonary Fibrosis Drugs Information
15.4.3 SWOT Analysis of Teva Pharmaceutical
15.4.4 Teva Pharmaceutical Idiopathic Pulmonary Fibrosis Drugs Revenue, Gross Margin and Market Share (2020-2025)
15.5 Glenmark Pharmaceuticals
15.5.1 Company Profile
15.5.2 Main Business and Idiopathic Pulmonary Fibrosis Drugs Information
15.5.3 SWOT Analysis of Glenmark Pharmaceuticals
15.5.4 Glenmark Pharmaceuticals Idiopathic Pulmonary Fibrosis Drugs Revenue, Gross Margin and Market Share (2020-2025)
15.6 ScieGen Pharmaceuticals
15.6.1 Company Profile
15.6.2 Main Business and Idiopathic Pulmonary Fibrosis Drugs Information
15.6.3 SWOT Analysis of ScieGen Pharmaceuticals
15.6.4 ScieGen Pharmaceuticals Idiopathic Pulmonary Fibrosis Drugs Revenue, Gross Margin and Market Share (2020-2025)
Please ask for sample pages for full companies list
Tables and Figures
Table Abbreviation and Acronyms
Table Research Scope of Idiopathic Pulmonary Fibrosis Drugs Report
Table Data Sources of Idiopathic Pulmonary Fibrosis Drugs Report
Table Major Assumptions of Idiopathic Pulmonary Fibrosis Drugs Report
Figure Market Size Estimated Method
Figure Major Forecasting Factors
Figure Idiopathic Pulmonary Fibrosis Drugs Picture
Table Idiopathic Pulmonary Fibrosis Drugs Classification
Table Idiopathic Pulmonary Fibrosis Drugs Applications
Table Drivers of Idiopathic Pulmonary Fibrosis Drugs Market
Table Restraints of Idiopathic Pulmonary Fibrosis Drugs Market
Table Opportunities of Idiopathic Pulmonary Fibrosis Drugs Market
Table Threats of Idiopathic Pulmonary Fibrosis Drugs Market
Table COVID-19 Impact for Idiopathic Pulmonary Fibrosis Drugs Market
Table Raw Materials Suppliers
Table Different Production Methods of Idiopathic Pulmonary Fibrosis Drugs
Table Cost Structure Analysis of Idiopathic Pulmonary Fibrosis Drugs
Table Key End Users
Table Latest News of Idiopathic Pulmonary Fibrosis Drugs Market
Table Merger and Acquisition
Table Planned/Future Project of Idiopathic Pulmonary Fibrosis Drugs Market
Table Policy of Idiopathic Pulmonary Fibrosis Drugs Market
Table 2020-2030 North America Idiopathic Pulmonary Fibrosis Drugs Market Size
Figure 2020-2030 North America Idiopathic Pulmonary Fibrosis Drugs Market Size and CAGR
Table 2020-2030 North America Idiopathic Pulmonary Fibrosis Drugs Market Size by Application
Table 2020-2025 North America Idiopathic Pulmonary Fibrosis Drugs Key Players Revenue
Table 2020-2025 North America Idiopathic Pulmonary Fibrosis Drugs Key Players Market Share
Table 2020-2030 North America Idiopathic Pulmonary Fibrosis Drugs Market Size by Type
Table 2020-2030 United States Idiopathic Pulmonary Fibrosis Drugs Market Size
Table 2020-2030 Canada Idiopathic Pulmonary Fibrosis Drugs Market Size
Table 2020-2030 Mexico Idiopathic Pulmonary Fibrosis Drugs Market Size
Table 2020-2030 South America Idiopathic Pulmonary Fibrosis Drugs Market Size
Figure 2020-2030 South America Idiopathic Pulmonary Fibrosis Drugs Market Size and CAGR
Table 2020-2030 South America Idiopathic Pulmonary Fibrosis Drugs Market Size by Application
Table 2020-2025 South America Idiopathic Pulmonary Fibrosis Drugs Key Players Revenue
Table 2020-2025 South America Idiopathic Pulmonary Fibrosis Drugs Key Players Market Share
Table 2020-2030 South America Idiopathic Pulmonary Fibrosis Drugs Market Size by Type
Table 2020-2030 Asia & Pacific Idiopathic Pulmonary Fibrosis Drugs Market Size
Figure 2020-2030 Asia & Pacific Idiopathic Pulmonary Fibrosis Drugs Market Size and CAGR
Table 2020-2030 Asia & Pacific Idiopathic Pulmonary Fibrosis Drugs Market Size by Application
Table 2020-2025 Asia & Pacific Idiopathic Pulmonary Fibrosis Drugs Key Players Revenue
Table 2020-2025 Asia & Pacific Idiopathic Pulmonary Fibrosis Drugs Key Players Market Share
Table 2020-2030 Asia & Pacific Idiopathic Pulmonary Fibrosis Drugs Market Size by Type
Table 2020-2030 China Idiopathic Pulmonary Fibrosis Drugs Market Size
Table 2020-2030 India Idiopathic Pulmonary Fibrosis Drugs Market Size
Table 2020-2030 Japan Idiopathic Pulmonary Fibrosis Drugs Market Size
Table 2020-2030 South Korea Idiopathic Pulmonary Fibrosis Drugs Market Size
Table 2020-2030 Southeast Asia Idiopathic Pulmonary Fibrosis Drugs Market Size
Table 2020-2030 Australia & New Zealand Idiopathic Pulmonary Fibrosis Drugs Market Size
Table 2020-2030 Europe Idiopathic Pulmonary Fibrosis Drugs Market Size
Figure 2020-2030 Europe Idiopathic Pulmonary Fibrosis Drugs Market Size and CAGR
Table 2020-2030 Europe Idiopathic Pulmonary Fibrosis Drugs Market Size by Application
Table 2020-2025 Europe Idiopathic Pulmonary Fibrosis Drugs Key Players Revenue
Table 2020-2025 Europe Idiopathic Pulmonary Fibrosis Drugs Key Players Market Share
Table 2020-2030 Europe Idiopathic Pulmonary Fibrosis Drugs Market Size by Type
Table 2020-2030 Germany Idiopathic Pulmonary Fibrosis Drugs Market Size
Table 2020-2030 France Idiopathic Pulmonary Fibrosis Drugs Market Size
Table 2020-2030 United Kingdom Idiopathic Pulmonary Fibrosis Drugs Market Size
Table 2020-2030 Italy Idiopathic Pulmonary Fibrosis Drugs Market Size
Table 2020-2030 Spain Idiopathic Pulmonary Fibrosis Drugs Market Size
Table 2020-2030 Belgium Idiopathic Pulmonary Fibrosis Drugs Market Size
Table 2020-2030 Netherlands Idiopathic Pulmonary Fibrosis Drugs Market Size
Table 2020-2030 Austria Idiopathic Pulmonary Fibrosis Drugs Market Size
Table 2020-2030 Poland Idiopathic Pulmonary Fibrosis Drugs Market Size
Table 2020-2030 Northern Europe Idiopathic Pulmonary Fibrosis Drugs Market Size
Table 2020-2030 MEA Idiopathic Pulmonary Fibrosis Drugs Market Size
Figure 2020-2030 MEA Idiopathic Pulmonary Fibrosis Drugs Market Size and CAGR
Table 2020-2030 MEA Idiopathic Pulmonary Fibrosis Drugs Market Size by Application
Table 2020-2025 MEA Idiopathic Pulmonary Fibrosis Drugs Key Players Revenue
Table 2020-2025 MEA Idiopathic Pulmonary Fibrosis Drugs Key Players Market Share
Table 2020-2030 MEA Idiopathic Pulmonary Fibrosis Drugs Market Size by Type
Table 2020-2025 Global Idiopathic Pulmonary Fibrosis Drugs Market Size by Region
Table 2020-2025 Global Idiopathic Pulmonary Fibrosis Drugs Market Size Share by Region
Table 2020-2025 Global Idiopathic Pulmonary Fibrosis Drugs Market Size by Application
Table 2020-2025 Global Idiopathic Pulmonary Fibrosis Drugs Market Share by Application
Table 2020-2025 Global Idiopathic Pulmonary Fibrosis Drugs Key Vendors Revenue
Figure 2020-2025 Global Idiopathic Pulmonary Fibrosis Drugs Market Size and Growth Rate
Table 2020-2025 Global Idiopathic Pulmonary Fibrosis Drugs Key Vendors Market Share
Table 2020-2025 Global Idiopathic Pulmonary Fibrosis Drugs Market Size by Type
Table 2020-2025 Global Idiopathic Pulmonary Fibrosis Drugs Market Share by Type
Table 2025-2030 Global Idiopathic Pulmonary Fibrosis Drugs Market Size by Region
Table 2025-2030 Global Idiopathic Pulmonary Fibrosis Drugs Market Size Share by Region
Table 2025-2030 Global Idiopathic Pulmonary Fibrosis Drugs Market Size by Application
Table 2025-2030 Global Idiopathic Pulmonary Fibrosis Drugs Market Share by Application
Table 2025-2030 Global Idiopathic Pulmonary Fibrosis Drugs Key Vendors Revenue
Figure 2025-2030 Global Idiopathic Pulmonary Fibrosis Drugs Market Size and Growth Rate
Table 2025-2030 Global Idiopathic Pulmonary Fibrosis Drugs Key Vendors Market Share
Table 2025-2030 Global Idiopathic Pulmonary Fibrosis Drugs Market Size by Type
Table 2025-2030 Idiopathic Pulmonary Fibrosis Drugs Global Market Share by Type
Table Boehringer Ingelheim Information
Table SWOT Analysis of Boehringer Ingelheim
Table 2020-2025 Boehringer Ingelheim Idiopathic Pulmonary Fibrosis Drugs Revenue Gross Profit Margin
Figure 2020-2025 Boehringer Ingelheim Idiopathic Pulmonary Fibrosis Drugs Revenue and Growth Rate
Figure 2020-2025 Boehringer Ingelheim Idiopathic Pulmonary Fibrosis Drugs Market Share
Table Roche Information
Table SWOT Analysis of Roche
Table 2020-2025 Roche Idiopathic Pulmonary Fibrosis Drugs Revenue Gross Profit Margin
Figure 2020-2025 Roche Idiopathic Pulmonary Fibrosis Drugs Revenue and Growth Rate
Figure 2020-2025 Roche Idiopathic Pulmonary Fibrosis Drugs Market Share
Table Sandoz Information
Table SWOT Analysis of Sandoz
Table 2020-2025 Sandoz Idiopathic Pulmonary Fibrosis Drugs Revenue Gross Profit Margin
Figure 2020-2025 Sandoz Idiopathic Pulmonary Fibrosis Drugs Revenue and Growth Rate
Figure 2020-2025 Sandoz Idiopathic Pulmonary Fibrosis Drugs Market Share
Table Teva Pharmaceutical Information
Table SWOT Analysis of Teva Pharmaceutical
Table 2020-2025 Teva Pharmaceutical Idiopathic Pulmonary Fibrosis Drugs Revenue Gross Profit Margin
Figure 2020-2025 Teva Pharmaceutical Idiopathic Pulmonary Fibrosis Drugs Revenue and Growth Rate
Figure 2020-2025 Teva Pharmaceutical Idiopathic Pulmonary Fibrosis Drugs Market Share
Table Glenmark Pharmaceuticals Information
Table SWOT Analysis of Glenmark Pharmaceuticals
Table 2020-2025 Glenmark Pharmaceuticals Idiopathic Pulmonary Fibrosis Drugs Revenue Gross Profit Margin
Figure 2020-2025 Glenmark Pharmaceuticals Idiopathic Pulmonary Fibrosis Drugs Revenue and Growth Rate
Figure 2020-2025 Glenmark Pharmaceuticals Idiopathic Pulmonary Fibrosis Drugs Market Share
Table ScieGen Pharmaceuticals Information
Table SWOT Analysis of ScieGen Pharmaceuticals
Table 2020-2025 ScieGen Pharmaceuticals Idiopathic Pulmonary Fibrosis Drugs Revenue Gross Profit Margin
Figure 2020-2025 ScieGen Pharmaceuticals Idiopathic Pulmonary Fibrosis Drugs Revenue and Growth Rate
Figure 2020-2025 ScieGen Pharmaceuticals Idiopathic Pulmonary Fibrosis Drugs Market Share
......
